Restore emotional well-being…naturally CHI HAPPINESS
↑ Serotonin
↑ Dopamine
↑ Norepinephrine Regulates mood, Regulates alertness, Regulates attention, compulsions motivation, pleasure Main Ingredients: Lilium, Anemarrhena LD50 = 15 g/kg Dose: 2-3 capsules, 2 times daily after meals. Chi Happiness vs Prozac on Chi Happiness vs Prozac on Serotonin (5HT) Levels in Mice Norepinephrine Levels in Mice Cerebral Cortex Hypothalamus Cerebral Cortex Hypothalamus Chi Happiness Chi Happiness Effect of Chi Happiness on increasing Effect of Chi Happiness on increasing serotonin levels in mice is the same as or even norepinephrine levels in mice is almost the better than Prozac. same as Prozac. Mechanisms of Action
Blocks monoamine oxidase action, increasing serotonin concentration
Blocks serotonin, norepinephrine and dopamine from being cleared from the synapse
→ greater concentration and effect on the synapses
Regulates an overactive Hypothalamus-Pituitary-Adrenal (HPA) axis, thus reducing
elevated adrenocorticotrophic hormone and cortisol concentration
Copyright 2008. Chi Research. Neither the entire flyer nor any part may be reproduced or transmitted in any form or by any means, electronic or mechanical, including photocopying, microfilming, and recording, or by any information storage and retrieval system, without permission in writing from the proprietary company at the risk of legal action.
CALL TOLL FREE: (800) 457-5708 WWW.CHI-HEALTH.COM
*These statements have not been evaluated by the Food & Drug Administration. This product is not intended to diagnose, prevent, treat or cure any diseases. Chi Happiness vs Prozac on Dopamine Levels in Mice Cerebral Cortex and Hypothalamus Chi Happiness mine level (pg C e re bral C orte x Hypothalamus Chi Happiness increases dopamine levels in the cerebral cortex and hypothalamus almost as much as Prozac. Dopamine levels are low in depression. Blocking reuptake of dopamine means greater concentration in the synapse, leading to more alertness and energy. Chi Happiness vs Prozac on Chi Happiness vs Prozac on Serum Cortisol in Mice Serum ACTH in Mice Chi Happiness Chi Happiness
Depression is characterized by an overactive Hypothalamus-Pituitary-Adrenal (HPA) axis causing an increase in the
secretion of corticotrophin-releasing factor. This leads to the increase of adrenocorticotrophic hormone (ACTH) and
cortisol concentration. Neuropsychobiology. 2001;44(2):74-7
Chi Happiness regulates an overactive HPA axis, as evidenced by the decrease in serum ACTH and cortisol levels in mice
Case Reports J.S., a 24-year-old male from FL, was diagnosed as a bipolar/ schizophrenic since the age of 13 and was very nervous and
shy. After taking Chi-Happiness and using the Mineral Infrared Therapy machine for 3 months, he improved dramatically and didn’t need Prozac anymore.
M. M., a 50-year-old female from NV, had severe pain for 2 years, causing depression. After taking Chi Happiness, "I started taking it immediately and within a couple of days I was already feeling a difference in the depression. I continued to take it and within two weeks I was back to myself. I wanted to see what would happen if I went off it, so I did just for a weekend and I started to go back into the depression. You can bet that I faithfully take the Chi-Happiness everyday now. It has made a difference in my life."
T.S., a 40-year-old female from NY, was taking Zoloft (200 mg) and Zyprexa (7.5 mg) for depression. Then she tried Chi Happiness. For 6 months now, she hasn’t been on the drugs.
S.K., a 37-year-old female from CA, had been taking Effexor for 3 years for her depression. Then she switched to Chi Happiness in Dec. 2004. She hasn’t used Effexor since.
Modeling the Architecture of the Olfactory System ∗Modeling the Architecture of the Drosophila Ol-factory SystemThe object of this paper is to present a model of the architecture of the olfactory systemof the Drosophila. Our initial model of the fly olfactory system (see Figure 1) consists of four cascadedbuilding blocks (networks). Each block models a transduction, information representa-tio
EIK studie Dit is een studie naar het effect, veiligheid en verdraagzaamheid van ezetimibe in combinatie met simvastatine therapie in de behandeling van adolescenten met heterozygote familiare hypercholesterolemie (FH). Deze Fase IIIb, multinationale, gerandomiseerde, dubbelblinde, gecontroleerde studie met parallelle groepen duurt 60 weken. Achtergrond van het onderzoek: Hypercholesterol